• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sapiens Reports Second Quarter 2025 Financial Results

    8/13/25 7:15:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology
    Get the next $SPNS alert in real time by email

    ROCHELLE PARK, N.J., Aug. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the second quarter ended June 30, 2025.

    Sapiens Logo

    Summary Results for Second Quarter 2025 (USD in millions, except per share data)



    GAAP



    Non-GAAP





    Q2 2025

    Q2 2024

    % Change

    Q2 2025

    Q2 2024

    % Change

    Revenue

    $141.6

    $136.8

    3.5 %

    $141.6

    $136.8

    3.5 %

    Gross Profit

    $61.9

    $60.1

    3.0 %

    $64.8

    $62.5

    3.8 %

    Gross Margin

    43.7 %

    43.9 %

     -20 bps

    45.8 %

    45.7 %

    10 bps

    Operating Income

    $16.8

    $21.9

    -23.2 %

    $23.1

    $24.8

    -7.1 %

    Operating Margin

    11.9 %

    16.0 %

     -410 bps

    16.3 %

    18.2 %

    -190 bps

    Net Income (*)

    $14.2

    $18.6

    -23.6 %

    $19.3

    $21.0

    -8.2 %

    Diluted EPS

    $0.25

    $0.33

    -24.2 %

    $0.34

    $0.37

    -8.1 %

    (*) Attributable to Sapiens' shareholders

    Roni Al-Dor, President and CEO of Sapiens, stated, "In the second quarter of 2025, we continued to execute on our strategic priorities, securing new deals and strengthening customer relationships across our Life, P&C, and Reinsurance segments.  Our insurance platform supports insurers in advancing digital transformation, improving operational efficiency, and adopting AI-driven innovation."

    Mr. Al-Dor continued, "During the quarter, we completed the acquisitions of Advantage Go and Candella, acquisitions that strengthen our P&C and Life growth. We reiterate our priority to continue platform innovation, increase cross-selling, accelerate cloud adoption, and expand the Life & Annuities business globally, all of which will serve as catalysts to accelerated growth in 2026."   

    Quarterly Results Conference Call

    Following our announcement that Sapiens has entered into a definitive agreement to be acquired by Advent, Sapiens will forgo its Q2 2025 Earnings Call scheduled for today.

    Non-GAAP Financial Measures

    This press release contains the following non-GAAP financial measures: non-GAAP revenue, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

     Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

    Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, and tax adjustments related to non-GAAP adjustments.

    Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

    To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

    Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

    The Company defines Annual Recurring Revenue ("ARR") as the annualized value of our revenue from customer subscriptions, term licenses, maintenance, application maintenance, and cloud solutions, which may not be the same as the timing and amount of revenue recognized. The ARR run rate is equal to the product of (i) the sum of these revenues in our most recently completed fiscal quarter, multiplied by (ii) four.

    The Company defines Adjusted EBITDA as net profit, adjusted to stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

    The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

    About Sapiens

    Sapiens International Corporation (NASDAQ and TASE: SPNS) is a global leader in intelligent insurance SaaS-based software solutions. With Sapiens' robust platform, customer-driven partnerships, and rich ecosystem, insurers are empowered to future-proof their organizations with operational excellence in a rapidly changing marketplace. Our SaaS-based Solutions help insurers harness the power of AI and advanced automation to support core solutions for property and casualty, workers' compensation, and life insurance, including reinsurance, financial & compliance, data & analytics, digital, and decision management. Sapiens boasts a longtime global presence, serving over 600 customers in more than 30 countries with its innovative offerings. Recognized by industry experts and selected for the Microsoft Top 100 Partner program, Sapiens is committed to partnering with our customers for their entire transformation journey and is continuously innovating to ensure their success. For more information visit sapiens or follow us on LinkedIn 

    Investor and Media Contact

    Yaffa Cohen-Ifrah

    Chief Marketing Officer and Head of Investor Relations, Sapiens

    Mobile: +1 917-533-4782

    Email: [email protected] 

    Investor Contact

    Kimberly Rogers

    Managing Director, Hayden IR

    Phone: +1 541-904-5075

    Email: [email protected] 

    Forward Looking Statements

    Certain matters discussed in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, and are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our most recent Annual Report on Form 20-F, which we filled with the SEC on March 31, 2022, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES                   

    CONDENSED CONSOLIDATED STATEMENT OF INCOME                   

    U.S. dollars in thousands (except per share amounts)







































      Three months ended



      Six months ended





     June 30,



     June 30,





    2025

    2024



    2025



    2024





     (unaudited)

     (unaudited)



     (unaudited)



     (unaudited)

















     Revenue



    141,602

    136,800



    277,707



    271,049

     Cost of revenue



    79,711

    76,696



    155,156



    153,385

















     Gross profit



    61,891

    60,104



    122,551



    117,664

















     Operating expenses:















     Research and development, net



    18,833

    16,809



    35,109



    33,330

     Selling, marketing, general and administrative



    26,261

    21,412



    49,449



    41,929

     Total operating expenses



    45,094

    38,221



    84,558



    75,259

















     Operating income



    16,797

    21,883



    37,993



    42,405

















     Financial and other (income) expenses, net



    (1,270)

    (1,109)



    (2,600)



    (2,201)

     Taxes on income



    3,681

    4,375



    8,173



    8,488

































     Net income



    14,386

    18,617



    32,420



    36,118

















     Attributable to non-controlling interest



     

    154

    -



    252



    141

















     Net income attributable to Sapiens' shareholders



     

    14,232

    18,617



    32,168



    35,977

































     Basic earnings per share



    0.25

    0.33



    0.58



    0.65

















     Diluted earnings per share



    0.25

    0.33



    0.57



    0.64

































    Weighted average number of shares outstanding used to

    compute basic earnings per share (in thousands)



    55,897

    55,797



    55,892



    55,771

















    Weighted average number of shares outstanding used to

    compute diluted earnings per share (in thousands)



    56,070

    56,163



    56,042



    56,072

     

     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES 

    RECONCILIATION OF GAAP TO NON-GAAP RESULTS

    U.S. dollars in thousands (except per share amounts)







































    Three months ended



    Six months ended





    June 30,



    June 30,





    2025



    2024



    2025



    2024





    (unaudited)



    (unaudited)



    (unaudited)



    (unaudited)



















    GAAP revenue



    141,602



    136,800



    277,707



    271,049

    Valuation adjustment on acquired deferred revenue



    -



    -



    -



    -

    Non-GAAP revenue



    141,602



    136,800



    277,707



    271,049



















    GAAP gross profit



    61,891



    60,104



    122,551



    117,664

    Amortization of capitalized software



    1,675



    1,569



    3,186



    3,114

    Amortization of other intangible assets



    1,272



    808



    2,096



    2,587

    Non-GAAP gross profit



    64,838



    62,481



    127,833



    123,365



















    GAAP operating income



    16,797



    21,883



    37,993



    42,405

    Gross profit adjustments



    2,947



    2,377



    5,282



    5,701

    Capitalization of software development



    (1,788)



    (1,823)



    (3,730)



    (3,540)

    Amortization of other intangible assets



    2,094



    1,223



    3,654



    2,456

    Stock-based compensation



    845



    811



    1,692



    1,583

    Acquisition-related costs *)



    2,182



    365



    2,743



    494

    Non-GAAP operating income



    23,077



    24,836



    47,634



    49,099



















      GAAP net income attributable to Sapiens'

      shareholders



                 

    14,232



    18,617



              

    32,168



    35,977

      Operating income adjustments



    6,280



    2,953



    9,641



    6,694

      Taxes on income



    (1,207)



    (529)



    (1,825)



    (1,209)

      Non-GAAP net income attributable to

      Sapiens' shareholders



    19,305



    21,041



    39,984



    41,462





















    (*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as tax, accounting and legal rendered until the acquisition date.

     

     

     

    Adjusted EBITDA Calculation

    U.S. dollars in thousands























    Three months ended



    Six months ended





     June 30,



     June 30,





    2025



    2024



    2025



    2024



















    GAAP operating profit



    16,797



    21,883



    37,993



    42,405



















    Non-GAAP adjustments:

















    Amortization of capitalized software



    1,675



    1,569



    3,186



    3,114

    Amortization of other intangible assets



    3,366



    2,031



    5,750



    5,043

    Capitalization of software development



    (1,788)



    (1,823)



    (3,730)



    (3,540)

    Stock-based compensation



    845



    811



    1,692



    1,583

    Compensation   related    to    acquisition   and

    acquisition-related costs



    2,182



    365



    2,743



    494



















    Non-GAAP operating profit



    23,077



    24,836



    47,634



    49,099



















    Depreciation



    1,064



    1,095



    2,036



    2,192



















    Adjusted EBITDA



    24,141



    25,931



    49,670



    51,291

     

     

     

    Summary of NON-GAAP Financial Information 

    U.S. dollars in thousands (except per share amounts)

























































    Q2 2025



    Q1 2025



    Q4 2024



    Q3 2024



    Q2 2024





















    Revenues

    141,602



    136,105



    134,305



    137,025



    136,800

    Gross profit

    64,838



    62,995



    62,692



    62,809



    62,481

    Operating income

    23,077



    24,557



    24,468



    25,101



    24,836

    Adjusted EBITDA

    24,141



    25,529



    25,359



    26,389



    25,931

    Net income to Sapiens' shareholders

    19,305



    20,679



    20,710



    21,091



    21,041





















    Diluted earnings per share

    0.34



    0.37



    0.37



    0.37



    0.37

     

     

     

    Annual Recurring Revenue ("ARR")

    U.S. dollars in thousands 











    Three months ended





    June 30,





    2025





    2024

    Annual Recurring Revenue





    199,646







    168,593

















     

     

     

    Non-GAAP Revenues by Geographic Breakdown

    U.S. dollars in thousands











































































    Q2 2025



    Q1 2025



    Q4 2024



    Q3 2024



    Q2 2024





















    North America

    59,782



    56,871



    56,753



    55,755



    57,918

    Europe

    70,095



    67,480



    65,624



    69,281



    66,072

    Rest of the World

    11,725



    11,754



    11,928



    11,989



    12,810





















    Total

    141,602



    136,105



    134,305



    137,025



    136,800

     

     

     

    Non-GAAP Revenue breakdown

    U.S. dollars in thousands

































    Three months ended



    Six months ended



    June 30,



    June 30,



    2025



    2024



    2025



    2024

















    Software products and re-occurring post-production services (*)

    109,859



    98,044



    217,916



    192,285

    Pre-production implementation services (**)

    31,743



    38,756



    59,791



    78,764

















    Total Revenues

    141,602



    136,800



    277,707



    271,049

















     



    Three months ended



    Six months ended



    June 30,



    June 30,



    2025



    2024



    2025



    2024

















    Software products and re-occurring post-production services (*)

    58,439



    52,237



    117,931



    102,577

    Pre-production implementation services (**)

    6,399



    10,244



    9,902



    20,788

















    Total Gross profit

    64,838



    62,481



    127,833



    123,365

     



    Three months ended



    Six months ended



    June 30,



    June 30,



    2025



    2024



    2025



    2024

















    Software products and re-occurring post-production services (*)

    53.2 %



    53.3 %



    54.1 %



    53.3 %

    Pre-production implementation services (**)

    20.2 %



    26.4 %



    16.6 %



    26.4 %

















    Gross Margin

    45.8 %



    45.7 %



    46.0 %



    45.5 %

    (*) Software products and re-occurring post-production services include mainly subscription, term license, maintenance, application maintenance, cloud solutions and post-production services. This revenue stream is a mix of recurring and re-occurring in nature.

    (**) Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature.

     

     

    Adjusted Free Cash-Flow

    U.S. dollars in thousands





























































    Q2 2025



    Q1 2025



    Q4 2024



    Q3 2024



    Q2 2024





















    Cash-flow from operating activities

    1,873



    25,353



    42,109



    13,083



    8,545

    Increase in capitalized software development costs

    (1,788)



    (1,942)



    (1,759)



    (1,834)



    (1,823)

    Capital expenditures

    (1,003)



    (366)



    (419)



    (1,125)



    (666)

    Free cash-flow

    (918)



    23,045



    39,931



    10,124



    6,056





















    Cash payments attributed to acquisition-related

     costs(*) (**)

    626



    -



    1,238



    124



    134





















    Adjusted free cash-flow

    (292)



    23,045



    41,169



    10,248



    6,190

    (*) Included in cash-flow from operating activities

    (**) Acquisition-related payments pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as completed or prospective third-party services, such as tax, accounting and legal rendered.

     

     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEET

    U.S. dollars in thousands















































    June 30,



    December 31,







    2025



    2024







     (unaudited)



     (unaudited)













     ASSETS























     CURRENT ASSETS











    Cash and cash equivalents



    64,541



    163,690



    Short-term bank deposit



    10,000



    52,500



    Trade receivables, net and unbilled receivables



    134,949



    99,603



    Other receivables and prepaid expenses



    30,334



    19,350



    Total current assets



    239,824



    335,143













     LONG-TERM ASSETS











    Property and equipment, net



    11,195



    10,656



    Severance pay fund



    3,065



    3,208



    Goodwill and intangible assets, net



    439,166



    302,472



    Operating lease right-of-use assets



    22,766



    20,746



    Other long-term assets



    23,628



    19,486



    Total long-term assets



    499,820



    356,568













     TOTAL ASSETS



    739,644



    691,711













    LIABILITIES AND EQUITY





















     CURRENT LIABILITIES











    Trade payables



    11,615



    8,414



    Current maturities of Series B Debentures



    19,804



    19,796



    Accrued expenses and other liabilities



    91,286



    77,390



    Current maturities of operating lease liabilities



    7,284



    6,440



    Deferred revenue



    44,697



    37,543



    Total current liabilities



    174,686



    149,583













     LONG-TERM LIABILITIES











    Series B Debentures, net of current maturities



    -



    19,792



    Deferred tax liabilities



    13,710



    6,899



    Other long-term liabilities



    11,260



    10,331



    Long-term operating lease liabilities



    18,289



    17,719



    Accrued severance pay



    9,580



    7,758



    Total long-term liabilities



    52,839



    62,499













    REDEEMABLE NON-CONTROLLING INTEREST



    13,809



    -













    EQUITY





    498,310



    479,629













    TOTAL LIABILITIES AND EQUITY



    739,644



    691,711











     

     

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

    CONSOLIDATED STATEMENT OF CASH FLOW

    U.S. dollars in thousands

















    For the six months ended June 30,



    2025



    2024



    (unaudited)



    (unaudited)

    Cash flows from operating activities:







    Net income

    32,420



    36,118

    Reconciliation of net income to net cash provided by operating activities:







    Depreciation of property and equipment

    2,036



    2,192

    Amortization of intangible assets and capitalized software

    8,936



    8,157

    Accretion of discount on Series B Debentures

    12



    22

    Capital (gain) loss from sale of property and equipment

    1



    (9)

    Stock-based compensation related to options issued to employees

    1,692



    1,583









    Net changes in operating assets and liabilities, net of amount acquired:







    Increase in trade receivables, net and unbilled receivables

    (13,047)



    (12,723)

    Decrease in deferred tax liabilities, net

    (1,874)



    (1,428)

    Decrease in other operating assets

    1,011



    3,445

    Increase in trade payables

    1,504



    4,446

    Decrease in other operating liabilities

    (8,290)



    (8,354)

    Increase (decrease) in deferred revenues

    1,966



    (6,587)

    Increase in accrued severance pay, net

    859



    171

    Net cash provided by operating activities

    27,226



    27,033









    Cash flows from investing activities:







    Purchase of property and equipment

    (1,399)



    (1,146)

    Proceeds from deposits

    42,390



    12,136

    Proceeds from sale of property and equipment

    27



    14

    Payments for business acquisitions, net of cash acquired

    (106,189)



    (375)

    Capitalized software development costs

    (3,730)



    (3,540)

    Net cash provided by (used in) investing activities

    (68,901)



    7,089









    Cash flows from financing activities:







    Proceeds from employee stock options exercised

    -



    98

    Distribution of dividend

    (37,037)



    (15,635)

    Repayment of Series B Debenture

    (19,796)



    (19,796)

    Acquisition deferred payment

    (455)



    -

    Acquisition of non-controlling interest

    -



    (4,131)









    Net cash used in financing activities

    (57,288)



    (39,464)









    Effect of exchange rate changes on cash and cash equivalents

    (186)



    1,272









    Decrease in cash and cash equivalents

    (99,149)



    (4,070)

    Cash and cash equivalents at the beginning of period

    163,690



    126,716









    Cash and cash equivalents at the end of period

    64,541



    122,646

     

     

     

    Debentures Covenants

    As of June 30, 2025, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

    Covenant 1 

    • Target shareholders' equity (excluding non-controlling interest): above $120 million.
    • Actual shareholders' equity (excluding non-controlling interest) equal to $498.3 million.

    Covenant 2

    • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
    • Actual ratio of net financial indebtedness to net capitalization equal to (12.25)%.

    Covenant 3

    • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
    • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (0.54).

     

    Logo: http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

     

    Cision View original content:https://www.prnewswire.com/news-releases/sapiens-reports-second-quarter-2025-financial-results-302528921.html

    SOURCE Sapiens International Corporation

    Get the next $SPNS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SPNS

    DatePrice TargetRatingAnalyst
    2/3/2025$36.00 → $28.00Buy → Hold
    Jefferies
    5/5/2023$24.00Equal Weight → Underweight
    Barclays
    1/23/2023$28.00Buy
    Goldman
    12/1/2022$20.00Underweight
    JP Morgan
    2/24/2022$38.00 → $30.00Buy
    Citigroup
    2/24/2022$40.00 → $36.00Buy
    Needham
    12/14/2021Neutral → Underweight
    JP Morgan
    12/14/2021$35.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $SPNS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sapiens Reports Second Quarter 2025 Financial Results

    ROCHELLE PARK, N.J., Aug. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the second quarter ended June 30, 2025. Summary Results for Second Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q2 2025 Q2 2024 % Change Q2 2025 Q2 2024 % Change Revenue $141.6 $136.8 3.5 % $141.6 $136.8 3.5 % Gross Profit $61.9 $60.1 3.0 % $64.8 $62.5 3.8 % Gross Margin 43.7 % 43.9 %  -20 bps 45.8 % 45.7 % 10 bps Operating Income $16.8 $21.9 -23.2 % $23.1 $24.8 -7.1 % Operating Margin 11.9 % 16.0 %  -410 bps 16.3 % 18.2 % -190 bps Net Inc

    8/13/25 7:15:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens to be acquired by Advent for $2.5 Billion

    Sapiens shareholders to receive $43.50 per share in cash, a 64% premium to Sapiens' undisturbed closing share price of $26.52 on August 8, 2025  KEY HIGHLIGHTS Sapiens shareholders will receive $43.50 per share in cash, representing a premium of approximately 64% over Sapiens' undisturbed closing share price of $26.52 on August 8, 2025.Transaction values Sapiens at approximately $2.5 billion.Advent's investment will accelerate Sapiens' innovation in SaaS-based insurance solutions.ROCHELLE PARK, N.J., Aug. 13, 2025 /PRNewswire/ -- Sapiens International Corporation N.V. (NASDAQ:SPNS) (TASE: SPNS), "Sapiens" or the "Company"), a global leader in intelligent SaaS-based software solutions to the

    8/13/25 1:12:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Named a "Dominant Provider" in Datos Insights' Life and Underwriting Report

    Sapiens UnderwritingPro is recognized in the top category of the "Life/Annuity/Benefits New Business and Underwriting Systems, 2025" report ROCHELLE PARK, N.J., Aug. 7, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a global leader in intelligent SaaS-based software solutions, today announced that Sapiens UnderwritingPro has been named a "Dominant Provider" in Datos Insights' "Life/Annuity/Benefits New Business and Underwriting Systems, 2025" report. This recognition validates the strength of Sapiens' underwriting technology for life, health, and annuities carriers. The latest version of Sapiens UnderwritingPro was released in February 2025. It features

    8/7/25 7:10:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sapiens Int'l downgraded by Jefferies with a new price target

    Jefferies downgraded Sapiens Int'l from Buy to Hold and set a new price target of $28.00 from $36.00 previously

    2/3/25 7:11:09 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Int'l downgraded by Barclays with a new price target

    Barclays downgraded Sapiens Int'l from Equal Weight to Underweight and set a new price target of $24.00

    5/5/23 7:20:13 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Goldman initiated coverage on Sapiens Int'l with a new price target

    Goldman initiated coverage of Sapiens Int'l with a rating of Buy and set a new price target of $28.00

    1/23/23 7:48:42 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    SEC Filings

    View All

    SEC Form 6-K filed by Sapiens International Corporation N.V.

    6-K - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

    8/14/25 7:34:23 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Sapiens International Corporation N.V.

    6-K - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

    8/13/25 7:26:45 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Sapiens International Corporation N.V.

    6-K - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

    8/13/25 6:43:40 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

    SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

    1/17/23 6:12:29 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

    SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

    7/28/22 6:03:57 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

    SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

    2/7/22 6:08:41 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Financials

    Live finance-specific insights

    View All

    Sapiens Reports Second Quarter 2025 Financial Results

    ROCHELLE PARK, N.J., Aug. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the second quarter ended June 30, 2025. Summary Results for Second Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q2 2025 Q2 2024 % Change Q2 2025 Q2 2024 % Change Revenue $141.6 $136.8 3.5 % $141.6 $136.8 3.5 % Gross Profit $61.9 $60.1 3.0 % $64.8 $62.5 3.8 % Gross Margin 43.7 % 43.9 %  -20 bps 45.8 % 45.7 % 10 bps Operating Income $16.8 $21.9 -23.2 % $23.1 $24.8 -7.1 % Operating Margin 11.9 % 16.0 %  -410 bps 16.3 % 18.2 % -190 bps Net Inc

    8/13/25 7:15:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    SAPIENS TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 13, 2025

    ROCHELLE PARK, N.J., July 23, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that it will report its financial results for the Second quarter of 2025 on Wednesday, August 13, 2025. Management will host a conference call and webcast on August 13, 2025, at 11:30 a.m. Eastern Time (6:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate: North America (toll-free): 1-888-642-5032 International: 972-3-9180608 UK: 0-808-101-2717 The live webcast of the call can be access

    7/23/25 7:35:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    Sapiens Reports First Quarter 2025 Financial Results

    ROCHELLE PARK, N.J., May 8, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the first quarter ended March 31, 2025.     Summary Results for First Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q1 2025 Q1 2024 % Change Q1 2025 Q1 2024 % Change Revenue $136.1 $134.2 1.4 % $136.1 $134.2 1.4 % Gross Profit $60.7 $57.6 5.4 % $63.0 $60.9 3.5 % Gross Margin 44.6 % 42.9 %  170 bps 46.3 % 45.4 %  90 bps Operating Income $21.2 $20.5 3.3 % $24.6 $24.3 1.2 % Operating Margin 15.6 % 15.3 %  30 bps 18.0 % 18.1 %  -10 bps Net Income

    5/8/25 6:08:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology

    $SPNS
    Leadership Updates

    Live Leadership Updates

    View All

    Sapiens Appoints Jamie Yoder as North America President and General Manager

    HOLON, Israel, April 26, 2021 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced the appointment of Jamie Yoder as President and General Manager of Sapiens North America. Mr. Yoder's depth of leadership experience in the insurance and technology sectors, including senior management positions at top global professional services firms (such as PwC), will further strengthen Sapiens' footprint, strategy, and operations in North America and globally. Sapiens will benefit from his strong acumen across various touchpoints within the insurance life cycle, especially in these times

    4/26/21 9:58:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology